GlobeImmune, Inc.
GlobeImmune, Inc. (GBIM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GBIM · as of Jun 8, 2026
Key Statistics
Explore GlobeImmune, Inc. Data
gbim stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gbim competitorsGBIM
ANTH
CMRA
FPMI
IAGX
NTIIStock Performance
Full HistoryAbout GlobeImmune, Inc.
GlobeImmune, Inc. a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therap…
what is globeimmune, inc. · gbim stock overview · globeimmune, inc. company profile · who is globeimmune, inc. ceo · gbim OTC · globeimmune, inc. headquarters · globeimmune, inc. business segments
About Stock Overview & Key Data
GlobeImmune, Inc. (GBIM) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 2, 2014. As of the latest trading session, GBIM stock price is $0.00, with a market capitalization of $575. The stock has returned -50.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2015, GlobeImmune, Inc. reported revenue of $6.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GlobeImmune, Inc. (GBIM) stock price is $0.00. The stock is traded on OTC under the ticker symbol GBIM. The 52-week range is $0.00 – $0.00.